https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-03-15 / J. Neurooncol. 2007 Sep;84(2):131-40https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-03-15 / J. Neurooncol. 2007 Sep;84(2):131-402007-03-15 00:00:002021-11-15 15:39:28Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002004-11-01 / Br. J. Cancer 2004 Nov;91(9):1656-62https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2004-11-01 / Br. J. Cancer 2004 Nov;91(9):1656-622004-11-01 00:00:002021-11-15 15:38:39Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002004-05-01 / J. Neurosurg. 2004 May;100(5 Suppl Pediatrics):492-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2004-05-01 / J. Neurosurg. 2004 May;100(5 Suppl Pediatrics):492-72004-05-01 00:00:002021-11-15 15:38:16Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2002-12-12 18:49:432019-02-12 18:50:31Editorial von Prof. Dr. Volker Schirrmacher zum Beitrag „Immuntherapeutische Strategien zur Behandlung solider Tumoren“
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2002-02-24 17:26:082019-02-12 18:54:26Beitrag mit Prof. Dr. Schirrmacher über den Stellenwert der Dendritischen Zellen im Einsatz gegen Krebszellen
Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells
/in Glioblastoma, International Publications, IOZK VeröffentlichungenDendritic cell vaccination in patients with malignant gliomas: current status and future directions
/in Glioblastoma, International Publications, IOZK VeröffentlichungenSurgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
/in Dendritic Cells, Glioblastoma, International Publications, IOZK VeröffentlichungenTransient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report
/in Brain Tumors in Children, Dendritic Cells, Glioblastoma, International Publications, IOZK VeröffentlichungenEditorial von Prof. Dr. Volker Schirrmacher zum Beitrag „Immuntherapeutische Strategien zur Behandlung solider Tumoren“
/in IOZK VeröffentlichungenBeitrag mit Prof. Dr. Schirrmacher über den Stellenwert der Dendritischen Zellen im Einsatz gegen Krebszellen
/in Externe Meldungen, IOZK In der Presse